June 13, 2017
Denver, Co. (Embargoed until 9:30 A.M. MT, June 13, 2017) — Norman E. Bolus, MSPH, MPH, CNMT, FSNMMI-TS, program director and assistant professor at the University of Alabama at Birmingham (UAB) School of Health Professions (SHP) Clinical and Diagnostics Sciences (CDS) Department for the Master of Science in Nuclear Medicine Technology Program and interim program director of the Master of Science in Health Physics Program in Birmingham, Alabama, has been elected as the 2017-2018 president-elect of the Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS). The new slate of officers was introduced during the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2017 Annual Meeting, June 10–14 in Denver, Colorado.
“As president-elect of the SNMMI-TS, I will focus on three goals that I ran on for this elected position: to change the legal title for nuclear medicine technologists so they are officially listed as professionals in the eyes of the U.S. government; to increase membership within the society; and to support advocacy efforts for the SNMMI-TS, including scope of practice issues within the profession,” Bolus stated.
Bolus has been a nuclear medicine technologist for nearly 28 years and has spent his career in various positions within the University of Alabama at Birmingham, both in the hospital and education sides of the university. He began his career as a staff technologist at UAB Hospital and made a lateral transfer to the nuclear medicine technology (NMT) program. In his capacity within the UAB NMT program he has been a technologist, lab instructor, teacher and clinical coordinator, and he became program director in 2007. In 2016 he was also named as interim program director of the UAB Master of Science in Health Physics program, which he was instrumental in beginning at the university in fall 2016.
Bolus has bachelor of science degrees in biology and nuclear medicine technology, both from UAB. He also holds two master’s degrees from the UAB School of Public Health—a Master of Public Health in Occupational Health and Safety with a radiation safety emphasis and a Master of Science in Public Health in Environmental Toxicology. His thesis for the MSPH degree was, “Identification and Critical Review of Research Relevant to Radiation Exposure During Computed Tomography Scan Procedures.” In addition to his SNMMI-TS membership, Bolus is a member of the American Society of Nuclear Cardiology, the Health Physics Society and the Alabama Chapter of Health Physics, and he is a lifetime member of the Alabama Society of Nuclear Medicine.
Bolus has been actively involved in SNMMI for many years. He is currently serving the last six months of a six-year term as editor in chief of the Journal of Nuclear Medicine Technology (JNMT). He is a past chair of the SNMMI-TS Educator’s Committee and has served on many SNMMI and SNMMI-TS committees through the years. He is also a past treasurer and a past president of the Southeastern Chapter of SNMMI. He has served in every elected position and is twice a past president of the Alabama Society of Nuclear Medicine.
Bolus was named a Fellow of the SNMMI-TS in June of 2012 and received the Outstanding Educator Award in June of 2010. He also received the Southeastern Chapter SNMMI-TS Distinguished Service Award in October of 2013.
The new SNMMI leadership team announced at the Annual Meeting also includes Kathleen M. Krisak, BS, CNMT, FSNMMI-TS, of Granby, Mass., as the 2017-18 SNMMI-TS president. SNMMI officers elected for 2017-18 are Bennett S. Greenspan, MD, MS, FACNM, FACR, Augusta, Georgia, as president; Satoshi Minoshima, MD, PhD, Salt Lake City, Utah, as president-elect; and Vasken Dilsizian, MD, Baltimore, Maryland, as vice president-elect.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI’s more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.